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Protein-glycan interactions are important regulators of a variety of biological processes, ranging from
immune recognition to anticoagulation. An important area of active research is directed toward under-
standing the role of host cell surface glycans as recognition sites for pathogen protein receptors. Recognition
of cell surface glycans is a widely employed strategy for a variety of pathogens, including bacteria, parasites,
and viruses. We present here a representative example of such an interaction: the binding of influenza A
hemagglutinin (HA) to specific sialylated glycans on the cell surface of human upper airway epithelial cells,
which initiates the infection cycle. We detail a generalizable strategy to understand the nature of protein-
glycan interactions both structurally and biochemically, using HA as amodel system. This strategy combines
a top-down approach using available structural information to define important contacts between glycans
and HA, with a bottom-up approach using data-mining and informatics approaches to identify the common
motifs that distinguish glycan binders from nonbinders. By probing protein-glycan interactions simulta-
neously through top-down and bottom-up approaches, we can scientifically validate a series of observa-
tions. This in turn provides additional confidence and surmounts known challenges in the study of protein-
glycan interactions, such as accounting for multivalency, and thus truly defines concepts such as specificity,
affinity, and avidity. With the advent of new technologies for glycomics—including glycan arrays, data-mining
solutions, and robust algorithms to model protein-glycan interactions—we anticipate that such combination
approaches will become tractable for a wide variety of protein-glycan interactions.Introduction
Complex glycans at the surface of cells and on circulating
signaling molecules play a fundamental role in determining
how a cell ‘‘sees’’ and responds to external events. In this
capacity, through interactions with proteins, complex glycans
modulate a variety of biological processes including pathogen
recognition, innate and acquired immunity (Alexopoulou et al.,
2007; Crocker et al., 2007; Rudd et al., 2004; van Die and
Cummings, 2006), glycoprotein targeting (Bhatia and Mukho-
padhyay, 1999; Helenius and Aebi, 2004; Varki et al., 2008),
adhesion (Kawashima et al., 2005; Lowe, 2002; Taylor and
Drickamer, 2007; Wang et al., 2005) and trafficking (Crocker,
2005; Smithson et al., 2001). Obtaining a complete picture of
a biological process or understanding higher-level organization
of a biological system accordingly requires decoding protein-
glycan interactions. In recognition of this practical need, there
has been a surge in the development of strategies for chemical
and chemoenzymatic synthesis of diverse glycan structures
(Blixt and Razi, 2006; Hanson et al., 2004; Seeberger and
Werz, 2007) that represent the common terminal motifs dis-
played as part of N- and O-linked glycans and glycolipids. To
properly present these glycans to their protein partners,
synthetic glycan motifs have been anchored to a variety of
platforms including polymeric backbones such as polyglutamic
acid and polyacrylamide, on dendrimers, and more recently on
glycan microarrays (Bovin et al., 2004; Collins and Paulson,
2004; Gambaryan et al., 2006; Mammen et al., 1995; Totani
et al., 2003).Chemistry & BioDespite these advances in the development of platforms to
study glycan-protein interactions, challenges remain in defining
glycan targets for the purpose of bridging the biochemical
and biophysical specificity of glycan-protein interactions with
the biological functions modulated by these interactions. In
the case of glycan-protein interactions, one size does not fit
all. Strategies that have proven informative in the areas of
genomics or proteomics may or may not facilitate our descrip-
tion of the glycome for several reasons. Glycan-protein interac-
tions, leading to either the activation or inhibition of a biological
response, are often not binary but rather involve more subtle
mediation of a signaling pathway. In addition, glycan-protein
interactions typically involve multivalency with respect to
both the protein and the glycan, 1:1 monovalent complexes
are often weak and display dissociation constants on the order
of 1 to 1000 mM. Biochemical/biophysical descriptions of
protein-glycan interactions therefore depend both on context
and experimental design. In this framework, the careful
description of experimental results, including an understanding
of both the strengths and limitations of an approach, is appre-
ciated. Finally, it is becoming clear that there are both finer and
coarser determinants to the specificity of a given protein-
glycan interaction than the simple monosaccharide sequence
of a glycan. Describing a glycan-binding sequence by its
monosaccharide composition and the linkages between the
monosaccharides, although important, in most cases does
not afford the same descriptive capacity as it does for other
biopolymers.logy 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 803
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ReviewFigure 1. The Influenza Infection Cycle
HA on the surface of the virus binds glycans termi-
nated by sialic acid with a specific linkage (green
or red), initiating fusion of the virus with the host
cell. This interaction is highly specific and is gov-
erned by the type of sialic acid linkage, the under-
lying sugars and branching pattern of the glycan
receptors. The other viral surface proteins are
the neuraminidase (NA) and the ion channel
protein M2. Once the virus is internalized in the
cell, fusion between viral and nuclear membranes
occurs, and complexes of RNA and proteins
termed viral ribonucleoprotein complexes (vRNPs)
are transported into the nucleus of the host cell.
The transcription to mRNA takes place in the host
cell nucleus followed by export and protein
synthesis. Also within the nucleus there is tran-
scription of the RNA genome. Assembly of progeny
vRNPs then occurs, with export, assembly of the
virus progeny, and finally budding of the newly
formed virus particles.Ensuring an accurate and complete picture of protein-glycan
interactions despite these difficulties demands studies that
integrate the basic biochemistry and molecular biology of
the system with analytical approaches, while simultaneously
enabling the appropriate translation to the biology. One of the
best-studied systems of glycan-protein interactions modulating
a biological function is that of the role of influenza A virus hemag-
glutinin (HA)-glycan interactions in viral pathogenesis. This review
presents an overview of the various technologies that have been
used for glycan receptor target definition for HA, their strengths
and limitations, and how an integrated framework enabled the
bridging of HA-glycan interactions with the host adaptation of
the virus. This integrated approach could serve as a framework
for target definition in other protein-glycan interactions.
Overview of Influenza A Viruses
Influenza A virus is a negative strain RNA virus with eight gene
segments. Three of the genes—hemagglutinin (HA), neuramini-
dase (NA), and the polymerase (PB)—have been shown to be
critical for infection and human-to-human transmission (Palese,
2004; Pappas et al., 2008; Tumpey et al., 2007) (Figure 1). Within
influenza A, five of the genome segments encoding the nucleo-
capsid protein (NP), the matrix proteins (M1 and M2), the
nonstructural proteins (NS1 and NS2), and polymerase proteins
(PB1, PB2 and PA) have maintained a relatively unbroken evolu-
tionary history in humans. In contrast, the two genes encoding
the major cell surface proteins (HA and NA) have been subjected
to substantial evolutionary pressure, including mutation (anti-
genic drift) and wholesale reassortment (antigenic shift). Due to
their variability, strains of influenza virus are identified based
on their serotype of HA and NA. There are currently 16 known
serotypes of HA and nine of NA.
At the moment there is substantial public health concern
surrounding the prospect of another influenza A pandemic and
its associated potential global implications. The past century
has seen four influenza pandemics. The first and most severe
occurred in 1918, involved an H1N1 virus, and led to the death
of at least 40 million people worldwide. Less serious pandemics
occurred in 1957, 1968, and 1977. Notably, in real time has been804 Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd Allthe advent of a reassorted H1N1 virus, viz., 2009 H1N1 or
‘‘swine’’ flu, which is antigenically dissimilar from seasonal,
circulating H1N1s and which has already been declared a
pandemic by the World Health Organization. Viruses containing
the 16 HA and nine NA serotypes are naturally present in wild
aquatic bird populations where they exist commensally without
causing disease, allowing birds to become a reservoir for influ-
enza strains. This is of specific concern because of the influenza
pandemics of the last century, those that arose from H2N2 (1957)
and H3N2 (1968), were avian-human reassortments that resulted
in the humanization of an avian-adapted virus and efficient
human-to-human transmission. Those genetic reassortments
that led to an avian-to-human switch yield a number of important
scientific and medical questions, not the least of which is what
changes lead away from infectivity and propagation in avian
species and toward human transmissibility? In light of a particular
influenza strain, H5N1 or the so-called bird flu, addressing these
questions becomes more critical. Transmission of avian H5N1
influenza viruses to humans has been observed thus far only
upon direct contact with infected poultry; the virus has not yet
demonstrated efficient human-to-human transmission ability.
Given that human infectivity has occurred and appreciating
that this virus strain is highly lethal (estimates are as high as
60% of infected individuals), the importance of comprehending
the mechanism and specificity of viral entry and infection as well
as identifying additional strategies for intervention is clear.
HA-Glycan Interactions: Description and Biological
Importance
The influenza A infection cycle can be described as a three-stage
process (Figure 1). The first stage is the attachment of HA of the
virus to complex glycan receptors on the host cells. Following
attachment, the virus is internalized by endocytosis where struc-
tural changes in HA produce the fusion of the viral membrane
with the endosomal membrane. Internalization facilitates activa-
tion of the ion channel activity of M2 and transport of the viral
RNA to the nucleus. In the nucleus, viral RNA undergoes replica-
tion and transcription. Newly synthesized proteins HA and NA
are secreted through the Golgi to the cell surface. Other proteinsrights reserved
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synthesized transcripts of viral RNA to form virions. These
virions, with HA and NA on their surface, then bulge from the
cell membrane. The action of NA, which cleaves the sialic-
acid-capped glycan structure and eliminates the interaction of
the host cell glycans with the newly formed virus particle, facili-
tates the release of progeny viruses from the host cells.
In the context of infectivity, the HA-glycan interaction is one of
the most critical components governing virus selectivity. HA
itself is a homotrimer (Figure 2); each monomer is synthesized
as a single polypeptide that contains a proteolytic site, that is
cleaved by host enzymes into two subunits (HA1 and HA2).
Numerous crystal structures of different HAs have been solved,
both alone and as co-crystals with various glycan structures (Ei-
sen et al., 1997; Gamblin et al., 2004; Ha et al., 2001, 2003;
Sauter et al., 1992; Skehel and Wiley, 2000; Stevens et al.,
2006c; Weis et al., 1988; Yamada et al., 2006). This body of
structural work offers valuable insights on the specificity of HA
binding. In tandem, biochemical studies identified a key feature
for binding of human-adapted HA to glycans terminated by N-
acetyl neuraminic acid linked a2/6 to galactose (N-acetyl-D-
neuraminic acid [Neu5Ac]a2/6 D-galactose [Gal], hereafter
referred to as a2/6) present on human respiratory epithelia
(Ibricevic et al., 2006; Russell et al., 2006; Shinya et al., 2006;
Skehel and Wiley, 2000; van Riel et al., 2007). These biochemical
findings have been correlated with the finding that human
respiratory tissue contains epithelial cells with a2/6 sialic-
acid-capped glycans (sites for attachment of human-adapted
viruses), whereas cells that primarily express glycans termi-
nated by N-acetyl neuraminic acid linked a2/3 to galactose
(Neu5Aca2/3Gal, hereafter referred to as a2/3), such as the
alveolar cells, are sites for attachment of avian-adapted viruses
(Shinya et al., 2006). These and other findings suggest that for
a virus to cross over from avian species to humans, its HA
must switch binding preference from a2/3 sialylated glycan
receptors, present in avian species, to a2/6 receptors (Connor
et al., 1994; Glaser et al., 2006; Kumari et al., 2007; Matrosovich
et al., 2004, 2007; Rogers et al., 1983; Russell et al., 2006; Tum-
pey et al., 2007), present in human upper airway epithelium.
Recent developments question the conception that the prefer-
ence of HA binding to a2/3 or a2/6 alone is sufficient to
designate human- versus avian-adapted HA (Bewley, 2008).
HA-Glycan Interactions: Answering Questions
and Generating Others
The specificity of HA binding to cell surface glycan structures
has been addressed not only by crystal structure analysis, but
also by the advent of powerful biochemical and biological tools
that provide significant insight and raise additional questions
regarding HA-glycan interactions.
Tools to Study HA-Glycan Interactions
A variety of biochemical methods have traditionally been used
to characterize the specificity of HA-glycan interactions. One
of the earliest methods, still in use today for probing the
glycan-binding specificity of a particular virus (through its HA)
involves measuring its ability to agglutinate red blood cells
(RBCs). RBCs from species such as chicken, turkey, horse,
guinea pigs and humans have been used (Connor et al., 1994;
Paulson and Rogers, 1987; Rogers and Paulson, 1983; TumpeyChemistry & Bioet al., 2007; Yang et al., 2007). Equine RBCs primarily contain
a2/3 glycans at their cell surface, whereas turkey and guinea
pig RBCs primarily contain a2/6 glycans. To augment the
usefulness and specificity of these models, the agglutination
method has been modified to include a step of complete desia-
lylation of species-specific RBCs followed by specific resialyla-
tion by either a2/3 or a2/6 sialyltransferase, creating
a more specific assay (Carroll et al., 1981). Agglutination and
other traditional hemagglutination assays permit the definition
of viruses’ specificity according to the sialic acid linkage, as
described above. These assays prove useful in the classification
of virus specificity and virulence. However, in its present form,
this assay does not allow the examination of specificity beyond
the sialic acid linkage, so probing the fine specificity of HA
binding is not possible. There are other drawbacks to the use
of RBC agglutination to define glycan-binding specificity of
a virus strain. First, there is possibly substantial variability in
the N- and O-linked cell surface glycans between different
batches of RBCs and related potential for variable response.
Additionally, the glycan structures on the cell surface of RBCs
are not similar to those present on the surface of cells of the
Figure 2. Structure of Trimeric HA
The cartoon rendering of a representative H1N1 HA (Protein Data Bank ID
1RU7) is shown where each chain (HA1 or HA2) is colored distinctly. The region
in HA1 involved in binding to sialylated glycan receptor and the region between
HA1 and HA2 involved in membrane fusion are also highlighted using dotted
circles.logy 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 805
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to, and elicit agglutination through glycan receptors that are
not present in the upper airway and therefore not physiologically
relevant.
Subsequent development of solid-phase fetuin capture
assays has provided a wealth of information on the glycan-
binding properties of influenza A viruses. In these assays, viruses
are immobilized on fetuin-coated surfaces and their binding to
various sialylated glycans (including polyvalent compounds) is
evaluated (Gambaryan et al., 1995, 2005, 2008; Gambaryan
and Matrosovich, 1992; Matrosovich et al., 2000). The presenta-
tion of the viruses is heterogeneous because the amount of virus
captured on the plate depends on the binding of the viral HA to
the sialylated glycans on fetuin. Furthermore, measuring the
binding of fixed viruses to glycans in solution is opposite to the
physiological event where glycans are less mobile on the cell
surface as compared with the virus.
Although not commonly used to investigate HA-glycan inter-
actions, isothermal titration calorimetry and surface plasmon
resonance have been widely employed to determine equilibrium
binding affinity constants and thermodynamic parameters for
glycan-protein interactions (Dam et al., 2009; Duverger et al.,
2003; Karamanska et al., 2008). These methodologies thus offer
promising tools for quantifying the binding affinity of HA-glycan
interactions.
Recent advances in the chemical and chemoenzymatic
synthesis of glycans have allowed for the development of glycan
array platforms. These platforms consist of hundreds of synthetic
glycan motifs (typically present on N- and O-linked glycoproteins
and glycolipids) displayed on the surface of the array. Multiple
types of arrays have been developed that utilize different strate-
gies including the formation of neoglycolipids (Fukui et al., 2002),
neoglycoproteins (Gildersleeve et al., 2008; Huang et al., 2008),
or the direct application of glycans to various surfaces (Blixt
et al., 2004; Grun et al., 2006; Karamanska et al., 2008; Liang
et al., 2008; Mercey et al., 2008; Xia et al., 2005). Several fine
reviews outline advances that have occurred recently in the
development of array technologies (Blixt et al., 2004; Feizi et al.,
2003; Houseman and Mrksich, 2002; Liang et al., 2008; Oyelaran
and Gildersleeve, 2007; Seeberger and Werz, 2007; Stevens
et al., 2006b). Among the various glycan array platforms, those
developed by the Consortium for Functional Glycomics (CFG)
are arguably the most accessible. More than 2000 samples
have been screened on CFG glycan arrays by the scientific
community, and data generated on the CFG glycan array
platform are disseminated freely to the public via web-based
interfaces (www.functionalglycomics.org/static/consortium/
resources/resourcecoreh.shtml). Recent studies have begun to
adapt these technologies toward the ultimate presentation of
natural glycans by harvesting glycans from the surface of cells
and imprinting these on a glycan array format (Song et al.,
2009), thusallowing one toprobe the glycan repertoire of a biolog-
ical system. In this manner, it is possible to create arrays specific
to a disease or biological process that permit the interpretation of
glycan-binding information in relation to that process.
The glycan array platforms developed by the CFG have already
been used to screen wild-type and mutant forms (mutations in
HA) of intact viruses and recombinant HAs belonging to the H1,
H2, H3, H5, H7, and H9 subtypes (Belser et al., 2008; Kumari806 Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd Alet al., 2007; Stevens et al., 2006a, 2008; Wan et al., 2008). These
studies have increased our understanding of HA binding to sialy-
lated glycan receptors by mapping the effect of glycan modifica-
tions, such as sulfation and fucosylation, on the HA-glycan inter-
actions. The scope of most of these studies is intended to serve
as a primary screen where high viral titers or HA concentrations
are used to define the binding preference of HA in terms of
a2/3 and/or a2/6 binding.
Tools to Bridge HA-Glycan Interactions with Viral
Pathogenesis
In 1989 Palese and colleagues first demonstrated the ability to
manipulate the influenza virus genome by developing a system
that allowed the use of standard recombinant DNA technology
to modify the genome of influenza virus to express foreign genes
(Luytjes et al., 1989). Their advance formed the basis for the devel-
opment of methods—termed reverse genetics—which permit
synthesis of the whole virus from the cDNAs of individual virus
genes (Hoffmann et al., 2000; Pleschka et al., 1996) (Figure 3). In
addition to the advent and widespread adoption of reverse
genetics, the emergence of ferrets as a model system to study
pathogenesisand contact and respiratorydroplet modes of trans-
mission (Lowen and Palese, 2007; Tumpey et al., 2007; van der
Laan et al., 2008) has proven of equal importance to the investiga-
tion of various aspects of influenza biology. Studies have demon-
strated that ferrets possess similar glycan structures to humans,
including a predominance of human-like a2/6 glycans in their
upper respiratory tract epithelium (Maines et al., 2006).
The ability to completely reconstruct the pandemic 1918 H1N1
viruses through reverse genetics and to test its virulence in
ferrets permitted a systematic exploration of the roles for various
viral genes in the virulence and transmissibility of influenza A
strains (Palese, 2004; Tumpey et al., 2005). Single gene reassor-
tants of the highly virulent pandemic human H1N1 (A/South
Figure 3. The Eight-Plasmid Polymerase(pol) I–II System for the
Generation of Influenza A Virus
Expression plasmids containing the eight viral cDNAs, inserted between the
human pol I promoter and the pol II promoter are transfected into cells. Because
each plasmid contains two different promoters, both cellular pol I and pol II will
transcribe the plasmid template in different orientations, which will result in the
production of vRNAs and mRNAs, respectively. Synthesis of the viral poly-
merase complex proteins (PB1, PB2, PA, and nucleoproteins) initiates the viral
replication cycle. Ultimately, the assembly of viral molecules results in the inter-
action of all synthesized molecules to generate infectious influenza A virus.l rights reserved
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Specificity with Biological Function of
Influenza A Virus
(A) Lectin staining of human upper respiratory
tissues provides a high-level picture of a2-3- and
a2-6- N- and O-linked glycans.
(B) Finer granularity on physiological glycans is ob-
tained by analyzing glycans derived from upper
respiratory epithelial cells using a combination of
analytical tools.
(C) The biochemical specificity of HA-glycan inter-
actions is characterized based on binding of
recombinant HA or whole viruses to glycan struc-
tures presented using a glycan array platform. The
array platform is designed to incorporate target
structures based on their predominant expression
in the upper respiratory tissues.
(D) The high-throughput data on binding of HA or
virus to hundreds of glycans on the array is
captured into a relational database and these
data are mined using methods to obtain rules or
classifiers that govern the glycan-binding speci-
ficity of wild-type and mutant HAs.
(E) The rules obtained from data mining are
corroborated using X-ray cocrystal structures of
HA-glycan complexes and molecular simulation
of HA-glycan interactions. The comprehensive
knowledge of the key determinants of HA-glycan
interactions obtained using this integrated frame-
work provides a much better handle to correlate
with the biological function of host adaptation of
the influenza A virus.Carolina/1/18 or SC18) virus with a contemporary epidemic
human H1N1 (A/Texas/36/91 or Tx91) virus showed that the
HA of SC18 had the most profound effect on the virulence of
the reassorted viruses, followed by the NA and PB1 genes (Pap-
pas et al., 2008). More recently, gene reassortment and reverse
genetics were employed to demonstrate that HA and PB2 are the
two critical genes conferring viral transmissibility via respiratory
droplets in ferrets (van Hoeven et al., 2009).
In one study pertaining to the SC18 virus, either a single point
mutation (NY18) or two point mutations (AV18) in HA resulted in
a virus that was unable to transmit efficiently via respiratory drop-
lets in the ferret model. This study permitted obtaining critical
details on the relationship between glycan-binding properties of
these 1918 H1N1 HAs (the other genes are identical between
SC18, NY18, and AV18) and their airborne transmissibility. The
RBC agglutination assay described above was used to charac-
terize SC18 and determined that it was an a2/6 binder, NY18
was a mixed a2/6/a2/3 binder, and AV18 was an a2/3
binder. The change in binding preference of NY18 and AV18 HA
in combination with an invariant NA can potentially influence
the tissue tropism and virulence of the viruses. NY18 and AV18
are more likely to infect deep lung tissues that preferentially
express a2/3 glycans. Given that the NA of these a2/3
glycan-binding viruses remains the same as that of SC18, it might
be inefficient at releasing the viral particles from the deep lung
tissues, leading to lower virulence of these mutant viruses.
When coupled with the fact that this virus transmitted ineffi-
ciently, the binding specificity of NY18 HA leads to the conclu-
sion that loss of a2/3 binding is necessary for efficient trans-Chemistry & Biomission but that the gain of a2/6 is insufficient. In an
apparent contradiction to this conclusion, Tx91—also a mixed
a2/3/a2/6 binding H1N1 virus—is able to transmit efficiently
(Tumpey et al., 2007). In other studies using H7 and H9 viruses
(Belser et al., 2008; Wan et al., 2008), it was observed that
although some of the wild-type or HA mutant viruses showed
substantial a2/6 binding, none transmitted via respiratory
droplets in the ferret model. However, in the same experimental
system the control human adapted H3N2 viruses that showed
similar a2/6 binding did transmit efficiently. These studies
suggest that defining glycan receptor targets of HA in terms of
a2/3 / a2/6 alone (using RBC agglutination, glycan arrays,
etc.) is inadequate to bridge with the biological role of HA in
human adaptation and viral virulence. In light of the critical role
of HA with respect to virulence and human adaptation of the
virus, it is clear that additional factors govern the specificity of
HA binding and determine whether a virus is able to efficiently
infect or transmit in humans.
Integrating Bottoms-Up and Top-Down Approaches
to Bridge Structure and Biology
Addressing the above issues required an integration of informa-
tion from complementary approaches that permit a move from
the biological to the structural space in an iterative and transitive
fashion (Figure 4). Each endeavor addressed a series of specific
questions, and collectively the data provide complementary,
overlapping sets of information that define the underlying spec-
ificity of influenza A HA. The bottom-up approach starts by
examining the structure of glycans present on the cell surfacelogy 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 807
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tion to quantitatively probe the affinity of HA to individual glycan
species.
Because human upper respiratory epithelia are the primary
targets for human-to-human transmission of influenza A virus, it
is essential to identify the types of sialylated glycans present on
these tissues. The characterization of the glycan repertoire for
a given tissue or cell type is challenging due to the complexity
associated with accessing and elucidating these structures.
While it is recognized that sialylated glycans of epithelial cells
are the receptor for HA (and accordingly virus) binding and inter-
nalization, epithelial cells themselves possess a broad array of
structurally diverse glycan structures. Addressing this diversity
requires orthogonal biochemical and biological tools that are
specific, sensitive, and robust. One approach that has been
employed is to bridge lectin staining of different tissue sections
with glycan profiling of representative human cell lines using
matrix-assisted laser desorption ionization (MALDI) mass spec-
trometry (MS) and MS/MS (to fragment glycans and provide
structural information) analyses (Comelli et al., 2006; Uematsu
et al., 2005). Other information-rich techniques have also been
employed, including capillary high-performance liquid chroma-
tography, liquid chromatography MS, and nuclear magnetic
resonance (Manzi et al., 2000; Norgard-Sumnicht et al., 2000).
Regardless of the particular analytical techniques employed,
the use of these complementary approaches provides a superior
quality of information because (1) data sets can be cross-
checked with one another, and (2) no single analytical approach,
no matter how powerful, has equally descriptive power for all
structures, especially glycans. Notably, in one approach, Sam-
bucus nigra agglutinin (SNA-I), a prototypic lectin that specifi-
cally binds to a2/6 glycans, and jacalin and concanavalin A
(Con A), which bind to specific motifs in O-linked (-Galb1-
Figure 5. Defining the Thermodynamics of
Glycan-Protein Interactions
In many cases, glycan-protein interactions are
multivalent, involving multiple 1:1 interactions
where the surfaces can either be two cells, or in
the case of influenza A, the virus particle and
a host cell. It is critical to define N, the number of
binding sites, to establish the precise relationship
between the thermodynamic parameters DGpoly,
Kpoly, and a. Development of biochemical and
array systems where N can be defined thus have
been and will continue to be a priority. Alterna-
tively, if N is unknown, information can still be
derived, but precise relationships, including coop-
erativity, cannot be determined.
3GalNAca- and -N-acetyl-D-glucosamine
[GlcNAc]b1-3GalNAca-) and N-linked
(trimannosyl core) glycans, respectively,
are used alone or in combination to
probe tissue samples (Chandrasekaran
et al., 2008). Using this lectin matrix in
an iterative manner provides detailed
information about glycan distribution. In
this case, it was shown that there is
a widespread distribution of N-linked
a2/6 (on ciliated cells) glycans and localized distribution of
O-linked a2/6 glycans on goblet cells in human tracheal
epithelia (Chandrasekaran et al., 2008). This analysis was then
confirmed and extended using detailed MALDI analysis of
glycans derived from representative human upper epithelia cells
to identify glycan composition, and MS/MS fragmentation to
determine their structural features, including the presence of
a lactosamine extension. Thus, MS and MS/MS information is
interpreted in the context of the information obtained from lectin
analysis (Chandrasekaran et al., 2008). This is but one example
of the application of different, overlapping analytical techniques
to obtain complementary data sets; other, equally valid strate-
gies can be devised.
Importantly, this coupled approach can provide a powerful
complement to the construction of natural arrays and increase
their utility to identify glycan-binding partners to proteins. Alter-
natively, such analysis can provide an important framework for
the development of quantitative array and array-like binding
assays using selected synthetic structures that are representa-
tive of cell surface glycans. For an analysis of this nature to be
valid, three key variables must be addressed and controlled to
ensure accurate interpretation. First, as is the case in biological
systems, glycan-protein interactions are typically multivalent
and the strength of such a contact should be described based
on its avidity. Numerous experimental setups have been
proposed to measure avidity, and Kiessling and colleagues
provide an excellent overview of many of these (Kiessling
et al., 2000). Regardless of platform, the most useful quantitative
information is obtained when N, the number of binding sites is
known, though even without N, useful thermodynamic informa-
tion can be determined (Mammen et al., 1998) (Figure 5). The
spatial arrangement of glycans and the glycan-binding sites
on proteins influence the structural valency (i.e., number of808 Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved
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motifs) of glycan-protein interactions (Dam and Brewer, 2008;
Dam et al., 2009). The spatial arrangement of glycan motifs
depends on the extent of branching (bi, tri, tetra, penta-antenn-
ary N-linked glycans) and spatial distribution of glycosylation
sites (clustered, linear, and globular) in different glycoprotein
structures. The spatial arrangement of glycan-binding sites in
a protein instead depends on the quaternary association of
individual domains. In the case of HA, there is a homotrimeric
association of identical domains resulting in three glycan-
binding sites per trimeric HA unit. Second, similar to biological
systems, the glycan structures on the surface should be in
excess. If this is not the case, ambiguous results might be ob-
tained, particularly if this situation is not made explicit when
plotting and calculating an association constant. Finally, the
response should be measured at various concentrations to
determine a dissociation constant (Kd
0, which is inverse of the
affinity constant, KNpoly).
In most of the earlier studies that focused on screening
different HAs on glycan arrays, the binding event was designated
as a single point ‘‘on’’ or ‘‘off.’’ This designation, though poten-
tially useful, necessarily misses the context of the interaction
and the relative biological importance of the interaction. More
recently, biochemical assays have been designed to screen
HA-glycan interactions over an entire range of HA concentra-
tions (Srinivasan et al., 2008) that take into consideration the
aforementioned factors, including spacing of the glycan motifs
in an array platform and the spatial arrangement of glycan-
binding sites. These assays have permitted quantification of
the relative binding affinity of HA to different glycan motifs. Using
Figure 6. Three-Dimensional Glycan
Topology Influences Molecular HA-Glycan
Interactions
(A) Interactions of HA with cone-like topology that
is characteristic of avian HA binding to a2-3 and
short a2-6 (such as multiantennary N-linked
glycans with single lactosamine branches termi-
nated with a2-6).
(B) Interactions of HA with umbrella-like topology
that is characteristic of polylactosamine branch
terminated with a2-6.
(C) Contacts between H1 HA with a fully open
umbrella-like topology glycan.
(D) Contacts between H9 HA and fully folded
umbrella-like topology glycans. Due to the larger
surface on HA spanned by umbrella-like topology,
the amino acids involved in making contacts with
umbrella-like topology glycans (shown in red in C
and D) are very different for different HAs.
such quantitative assays, it has been
demonstrated that the human-adapted
HAs share a high binding affinity to a2/
6 glycans (particularly those that have
multiple lactosamine repeats) that in turn
correlate with their efficient airborne
transmissibility (Maines et al., 2009; Srini-
vasan et al., 2008). Viruses of avian or
swine origin although known to infect
humans could be distinguished from the
human-adapted viruses based on their
quantitative a2/6 binding affinity of their respective HAs (Chan-
drasekaran et al., 2008; Maines et al., 2009).
Analysis employing the top-down approach originates from
consideration of the molecular and structural aspects of
HA-glycan interactions and correlates these aspects with the
biochemical binding affinities. Using glycan conformational
analysis, examination of HA-glycan cocrystal structures demon-
strated that glycan topology (or three-dimensional shape of the
glycan) plays a critical role in distinguishing binding of a2/3
and a2/6 glycans to avian and human-adapted HAs (Bewley,
2008; Chandrasekaran et al., 2008). Analysis of the various
crystal structures indicated that a highly conserved set of amino
acids Tyr98, Ser/Thr136, Trp153, His183, Leu/Ile194 (numbered
based on H3 HA) across different HA subtypes are involved in
anchoring the sialic acid. The specificity of HA to either a2/3
or a2/6 is governed by an extended range of interactions within
the glycan-binding site—not only with the sialic acid, but also
with the glycosidic oxygen atom and monosaccharides beyond
sialic acid.
The ensemble of conformations sampled by the a2/3 and
a2/6 glycans in the binding site of HA was described using
a shape-based topological description. In the case of a2/3
glycans, the conformations sampled by the Neu5Aca2/3Gal
linkage (keeping the Neu5Ac anchored) and the sugars beyond
this linkage (at the reducing end) span a region on the binding
surface of HA that resembles a ‘‘cone.’’ The assembly of these
conformations is therefore described by the term cone-like
topology (Figure 6).
When contrasted with the Neu5Aca2/3Gal linkage, the pres-
ence of the C6-C5 bond within the Neu5Aca2/6Gal linkageChemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 809
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conformations sampled by Neu5Aca2/6Gal linkage (keeping
the Neu5Ac anchored) and the sugars beyond this linkage (at
the reducing end) thus span a wider region on the HA binding
surface. One part of this wider region is similar to the cone-like
surface and the other part resembles a space that is readily
described by the opening of an umbrella from a fully folded to
a fully open form. In contrast to the cone-like topology, the set
of conformations that sample this other region is better
described using the term umbrella-like topology (Figure 6). In
this case, the stem of the umbrella is occupied by the
Neu5Aca2-6Gal-motif and the spokes of the umbrella (that are
the flexible part causing the opening and closing) are occupied
by the sugars at the reducing end of Gal.
The defining characteristic of glycan conformations that span
a cone-like topology is that the majority of the interactions with
the HA are made by a three-sugar (or trisaccharide) a2/3
(Neu5Aca2/3Galb1/3/4GlcNAc-) or a2/6 (Neu5Aca2/
6Galb1/4GlcNAc-) motif. However, the glycan conformations
that sample the umbrella-like topology are such that longer
oligosaccharides (beyond a trisaccharide) make substantial
contacts with the binding site on HA.
Using these shape-based definitions of the flexible glycan
conformation, it has been shown that the umbrella-like topology
is predominantly adopted by a2/6 glycans that possess at
least four sugars including the Neu5Ac, for example, poly-lactos-
amine branches terminated by a2/6-linked Neu5Ac (long a2/
6). The cone-like topology can instead be adopted by both a2/
3 and a2/6 glycans. In the case of a2/6 glycans, those with a
three-sugar a2/6 motif, such as N-linked glycans having single
lactosamine branches terminated by a2/6 linked Neu5Ac
(short a2/6), are more likely to adopt cone-like topology as
compared with the long a2/6 branch.
Applying the topology-based description of glycan conforma-
tion to the analysis of HA-glycan cocrystal structures revealed
that the umbrella-like topology was characteristic of long a2/
6 motifs interacting with human adapted H1 and H3 HAs and
the cone-like topology was characteristic of a2/3 glycans inter-
acting with avian HA. Because the avian HA binding pocket is
well-suited for maximum contacts with cone-like topology, it is
probable that a2/6 glycans, particularly those with short
a2/6 motifs, will adopt a cone-like topology in the glycan-
binding site of avian HA. More recently, the role of glycan
topology in molecular HA-glycan interactions was investigated
using molecular dynamics (MD) simulations (Xu et al., 2009).
Findings from this study support the notion that the umbrella-
like topology is energetically preferred by glycans upon binding
to human-adapted HA. The adoption of an umbrella-like
topology by a long a2/6 motif in an avian H5 HA-binding site
was associated with a high conformational entropy penalty in
comparison with the adoption of this topology in the human-
adapted H3 HA-binding site. These studies have further
extended the definition of glycan topology using other parame-
ters such as glycosidic torsion angles of sugars beyond the
terminal sialic acid linkage and volume occupied by the different
glycan topologies.
The above molecular and structural analyses of HA-glycan
interactions offer a framework for the interpretation of glycan array
data (Figure 4). Data-mining tools have been developed to identify810 Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd Alpatterns among binders (candidate ligands identified on the array)
and nonbinders. These patterns are defined using glycan features
that are abstracted from the glycan structures tested, for example
as part of a glycan array. The combination of patterns from binders
and nonbinders provides rules, or classifiers, that define glycan-
binding motifs for a given HA. These classifiers can be used to
corroborate the structural aspects of glycan-HA interactions ob-
tained from analysis of the cocrystal structures. For instance,
the a2/3 classifiers define motifs in terms of substitutions
around a trisaccharide Neu5Aca2/3Galb1/3/4GlcNAcb1/,
whereas a2/6 classifiers define length-dependent motif that
terminates in Neu5Aca2/6Galb1/4GlcNAcb1/ structure.
Additionally, from an analysis of crystal structures and dock-
ing of glycan structures, it is possible to estimate DGmono, or the
strength of a monovalent glycan-protein interaction (Figure 5).
Several advances have improved the force fields used to model
glycans and protein-glycan interactions (Case et al., 2005;
Kirschner et al., 2008). These theoretical methods have become
remarkably effective at predicting carbohydrate 3D structures,
since the advent of accurate carbohydrate-specific force
fields (Woods, 1998) and the advances in timescales that are
accessible to MD simulations. All commonly employed biomo-
lecular simulation packages (AMBER, CHARMM, GROMOS,
etc.) now include high-quality carbohydrate force fields. There
are currently several methods to calculate binding free energies
(DG). The most accurate of these computes relative binding affin-
ities for two related ligands by mutating one molecule onto
another. Such ‘‘computational alchemy’’ can be performed by
thermodynamic integration, but is limited to predicting relative
binding energies for structurally similar ligands. Although the pre-
dicted interaction energies from these docking methods might
only be qualitative, the resultant structures of the ligand-protein
complexes provides additional information on the interactions.
In conclusion, the recent development of biochemical and
biophysical tools truly enables the scientific community to
rapidly and thoroughly address some fundamental aspects of
describing glycan-protein interactions. By combining quantita-
tive binding affinity information obtained from the array with
molecular simulations, it is possible to correlate changes in the
enthalpic and entropic contributions of the monovalent glycan-
protein interaction with the quantitative differences in relative
glycan-binding affinity. By identifying biochemical systems
where multivalency can be taken into account (and hence define
N in a rigorous manner), it is possible to define avidity and
provide additional context to the glycan-protein interactions,
which can be carried through to biological studies.
Framework for Role Of HA-Glycan Interactions
in Influenza A Virus Biology
The intersection of the bottom-up and top-down approaches
highlight the fact that for a virus to efficiently infect humans, it
must bind to glycans that can adopt the umbrella-like topology
(for example sialylated structures containing multiple lactos-
amine repeats, i.e., long a2/6). Thus, the structural topology
of the glycan and not just the linkage appears to govern HA-
binding specificity. This framework not only takes into account
glycan structure in the context of protein binding, but also
resolves the apparent inconsistencies between the binding and
transmission data for SC18, NY18, AV18, and Tx91. SC18 andl rights reserved
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Shown on the left are residues in positions 186, 187, 189, 190, 219 and 227 of SC18 HA (cartoon representation in gray) in complex with an a2-6 oligosaccharide
(Neu5Aca2-6Galb1-4GlcNAcb1-3Galb1-4Glc) (Srinivasan, et al., 2008). The oligosaccharide is shown in stick representation colored orange (carbon atoms). The
network of interactions is shown in dotted gray lines. Shown on the right are the same residue positions in structural complex of CA/04 HA (cartoon representation
in violet) with the same a2-6 oligosaccharide (Maines, et al., 2009). The presence of the unique combination of Ile219 and Glu227 is not favorable for the optimal
positioning of Asp 190 (as seen on the left) for contacts with the a2-6 oligosaccharide. Lys222 is also shown as it is positioned to interact with Glu227.Tx91, both efficient transmitters, bind with high affinity to glycans
that adopt an umbrella-like topology, whereas NY18 and AV18,
which are inefficient transmitters, bind with higher affinity to
cone-like glycans, including glycans that either have a2/3 or
a2/6 sialic acid. This framework demonstrates that description
of HA-glycan interactions based on trans and cis conformations
(adopted by a2/3 and a2/6 linkages, respectively) alone does
not fully capture the structural features and conformational flex-
ibility of the diverse sialylated glycans observed in human
tissues. However, cone-like and umbrella-like classifications
are able to fully capture the conformational plurality of theseChemistry & Bioglycans and their binding to HA. Significantly, these classifica-
tions are able to distinguish the a2/3 and a2/6 binding of
avian- and swine- adapted HAs from that of the a2/6 binding
of human adapted HAs (Figure 7). Moreover, H1, H5, and H9
are of different structural clades and hence have distinct spatial
arrangement of residues in the glycan-binding sites. The confor-
mational flexibility of the a2/6 permits different types of
umbrella-like topologies in the glycan-binding sites to accom-
modate the diverse constraints imposed by the different struc-
tural clades of HA (Figure 6). These observations suggest that it
is challenging to design mutations in either H5 or H7 HA basedlogy 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 811
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Reviewsimply on the characteristic changes in a few residues in H1 and
H3 HAs that lead to their human adaptation. A set of mutations
must instead occur that accommodate umbrella-like glycans in
the context of the binding pocket, which is subtly distinct for
each HA structural clade.
Conclusion
Lessons learned from the study of glycans, and particularly the
HA example presented here, highlight: (1) the need to employ
multiple biophysical, bioanalytical, and biological approaches
to ultimately define the binding specificity of HA, and (2) the fact
that because different cell types have a distinct cell surface glycan
repertoire, studies employed using cell culture or any animal
model must be carefully interpreted, because glycan structures
present on cells in culture or in a given animal might not be
reflective of the structures present on the surface of primary cells
within the tissue. For example, the use of mice and Madin-Darby
canine kidney cells to characterize virus infectivity (Hatakeyama
et al., 2005; Stray et al., 2000) might not be ideal owing to differ-
ences in the glycan receptors present in them as compared
with physiologically relevant cells.
The development of a systematic understanding of the
receptor binding specificity of the HA from various influenza
strains is anticipated to help address a number of critical ques-
tions, including what defines an avian influenza strain versus
one that has become humanized, and what mutations in HA
enable the conversion of a strain from an avian virus to one
capable of efficient human-to-human transmission. Under-
standing the receptor specificity of HA as well as the set of muta-
tions that allow a virus to gain the ability to recognize human-like
glycans of the upper respiratory tract provides insight into the
epidemic and pandemic potential of various strains. Addressing
these questions is not only of great scientific significance, but
also is immediately pertinent in light of the rise of H5N1 and
the specter that it could become fully ‘‘humanized’’ through
mutations. The application of approaches outlined in this review,
as well as others, should illuminate novel strategies for the devel-
opment of vaccines and/or therapeutics.
Recent developments in the glycomics analysis of influenza in
many respects offer an example for future studies in glycobiol-
ogy. The role of glycans in cellular events, where modulation
tends to be more a function of avidity and presentation (context)
rather than a simple on/off event, and integration of biochemical,
structural, data-mining, and in vivo studies, are critical to ensure
accurate interpretation and extension of findings. With the advent
of analytical, synthetic, and computational tools to interrogate
protein-glycan interactions, it is possible to design a framework
such as that presented here for HA, to study many such biological
systems. We anticipate that the availability of such tools, through
the efforts of both large-scale glycomics research initiatives and
individual researchers, will dramatically increase our under-
standing of the glycome and its role in fundamental biology.
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